These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25677664)

  • 41. Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
    Martín-Martín ML; Bartolomé-Nebreda JM; Conde-Ceide S; Alonso de Diego SA; López S; Martínez-Viturro CM; Tong HM; Lavreysen H; Macdonald GJ; Steckler T; Mackie C; Bridges TM; Daniels JS; Niswender CM; Noetzel MJ; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1310-7. PubMed ID: 25683622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent and selective Bruton's tyrosine kinase inhibitors: discovery of GDC-0834.
    Young WB; Barbosa J; Blomgren P; Bremer MC; Crawford JJ; Dambach D; Gallion S; Hymowitz SG; Kropf JE; Lee SH; Liu L; Lubach JW; Macaluso J; Maciejewski P; Maurer B; Mitchell SA; Ortwine DF; Di Paolo J; Reif K; Scheerens H; Schmitt A; Sowell CG; Wang X; Wong H; Xiong JM; Xu J; Zhao Z; Currie KS
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1333-7. PubMed ID: 25701252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1.
    Najjar M; Suebsuwong C; Ray SS; Thapa RJ; Maki JL; Nogusa S; Shah S; Saleh D; Gough PJ; Bertin J; Yuan J; Balachandran S; Cuny GD; Degterev A
    Cell Rep; 2015 Mar; 10(11):1850-60. PubMed ID: 25801024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88.
    Dzierba CD; Bi Y; Dasgupta B; Hartz RA; Ahuja V; Cianchetta G; Kumi G; Dong L; Aleem S; Fink C; Garcia Y; Green M; Han J; Kwon S; Qiao Y; Wang J; Zhang Y; Liu Y; Zipp G; Liang Z; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Grace J; Wilson A; Nouraldeen A; Westphal R; Kimball D; Carson K; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1448-52. PubMed ID: 25690789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol efflux.
    Gillespie MA; Gold ES; Ramsey SA; Podolsky I; Aderem A; Ranish JA
    EMBO J; 2015 May; 34(9):1244-58. PubMed ID: 25755249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting selective liver X receptor β agonists using multiple machine learning methods.
    Li Y; Wang L; Liu Z; Li C; Xu J; Gu Q; Xu J
    Mol Biosyst; 2015 May; 11(5):1241-50. PubMed ID: 25734698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.
    Bindesbøll C; Fan Q; Nørgaard RC; MacPherson L; Ruan HB; Wu J; Pedersen TÅ; Steffensen KR; Yang X; Matthews J; Mandrup S; Nebb HI; Grønning-Wang LM
    J Lipid Res; 2015 Apr; 56(4):771-85. PubMed ID: 25724563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.
    Telen MJ; Wun T; McCavit TL; De Castro LM; Krishnamurti L; Lanzkron S; Hsu LL; Smith WR; Rhee S; Magnani JL; Thackray H
    Blood; 2015 Apr; 125(17):2656-64. PubMed ID: 25733584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects.
    Cannon MV; Yu H; Candido WM; Dokter MM; Lindstedt EL; Silljé HH; van Gilst WH; de Boer RA
    Eur J Heart Fail; 2015 Mar; 17(3):273-82. PubMed ID: 25684370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia.
    Sharman J; Hawkins M; Kolibaba K; Boxer M; Klein L; Wu M; Hu J; Abella S; Yasenchak C
    Blood; 2015 Apr; 125(15):2336-43. PubMed ID: 25696919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists.
    Austin RP; Bennion C; Bonnert RV; Cheema L; Cook AR; Cox RJ; Ebden MR; Gaw A; Grime K; Meghani P; Nicholls D; Phillips C; Smith N; Steele J; Stonehouse JP
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1616-20. PubMed ID: 25708618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mer signaling increases the abundance of the transcription factor LXR to promote the resolution of acute sterile inflammation.
    Choi JY; Seo JY; Yoon YS; Lee YJ; Kim HS; Kang JL
    Sci Signal; 2015 Feb; 8(365):ra21. PubMed ID: 25714463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor β-selective agonists.
    Koura M; Matsuda T; Okuda A; Watanabe Y; Yamaguchi Y; Kurobuchi S; Matsumoto Y; Shibuya K
    Bioorg Med Chem Lett; 2015 Jul; 25(13):2668-74. PubMed ID: 25998501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ranolazine reduces remodeling of the right ventricle and provoked arrhythmias in rats with pulmonary hypertension.
    Liles JT; Hoyer K; Oliver J; Chi L; Dhalla AK; Belardinelli L
    J Pharmacol Exp Ther; 2015 Jun; 353(3):480-9. PubMed ID: 25770134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice.
    Al-Barazanji K; McNulty J; Binz J; Generaux C; Benson W; Young A; Chen L
    J Pharmacol Exp Ther; 2015 Jun; 353(3):496-504. PubMed ID: 25770135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kibdelomycin is a bactericidal broad-spectrum aerobic antibacterial agent.
    Singh SB; Dayananth P; Balibar CJ; Garlisi CG; Lu J; Kishii R; Takei M; Fukuda Y; Ha S; Young K
    Antimicrob Agents Chemother; 2015; 59(6):3474-81. PubMed ID: 25845866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors.
    Zou B; Chan WL; Ding M; Leong SY; Nilar S; Seah PG; Liu W; Karuna R; Blasco F; Yip A; Chao A; Susila A; Dong H; Wang QY; Xu HY; Chan K; Wan KF; Gu F; Diagana TT; Wagner T; Dix I; Shi PY; Smith PW
    ACS Med Chem Lett; 2015 Mar; 6(3):344-8. PubMed ID: 25878766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remembering your A, B, C's: Alzheimer's disease and ABCA1.
    Lewandowski CT; Laham MS; Thatcher GRJ
    Acta Pharm Sin B; 2022 Mar; 12(3):995-1018. PubMed ID: 35530134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Saringosterol from
    Yan Y; Niu Z; Wang B; Zhao S; Sun C; Wu Y; Li Y; Ying H; Liu H
    Mar Drugs; 2021 Aug; 19(9):. PubMed ID: 34564147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches.
    Chen M; Yang F; Kang J; Gan H; Yang X; Lai X; Gao Y
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29867043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.